These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 26717533

  • 1. Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.
    Durgam S, Cutler AJ, Lu K, Migliore R, Ruth A, Laszlovszky I, Németh G, Meltzer HY.
    J Clin Psychiatry; 2015 Dec; 76(12):e1574-82. PubMed ID: 26717533
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
    Calabrese JR, Keck PE, Starace A, Lu K, Ruth A, Laszlovszky I, Németh G, Durgam S.
    J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.
    Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I.
    Schizophr Res; 2014 Feb; 152(2-3):450-7. PubMed ID: 24412468
    [Abstract] [Full Text] [Related]

  • 4. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study.
    Kane JM, Peters-Strickland T, Baker RA, Hertel P, Eramo A, Jin N, Perry PP, Gara M, McQuade RD, Carson WH, Sanchez R.
    J Clin Psychiatry; 2014 Nov; 75(11):1254-60. PubMed ID: 25188501
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.
    Meltzer HY, Risinger R, Nasrallah HA, Du Y, Zummo J, Corey L, Bose A, Stankovic S, Silverman BL, Ehrich EW.
    J Clin Psychiatry; 2015 Aug; 76(8):1085-90. PubMed ID: 26114240
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
    Durgam S, Earley W, Guo H, Li D, Németh G, Laszlovszky I, Fava M, Montgomery SA.
    J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.
    Kane JM, Zukin S, Wang Y, Lu K, Ruth A, Nagy K, Laszlovszky I, Durgam S.
    J Clin Psychopharmacol; 2015 Aug; 35(4):367-73. PubMed ID: 26075487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.
    Durgam S, Earley W, Lipschitz A, Guo H, Laszlovszky I, Németh G, Vieta E, Calabrese JR, Yatham LN.
    Am J Psychiatry; 2016 Mar 01; 173(3):271-81. PubMed ID: 26541814
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
    Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I.
    Bipolar Disord; 2015 Feb 01; 17(1):63-75. PubMed ID: 25056368
    [Abstract] [Full Text] [Related]

  • 12. The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials.
    Citrome L, Durgam S, Lu K, Ferguson P, Laszlovszky I.
    J Clin Psychiatry; 2016 Jan 01; 77(1):109-15. PubMed ID: 26845266
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.
    Earley W, Guo H, Daniel D, Nasrallah H, Durgam S, Zhong Y, Patel M, Barabássy Á, Szatmári B, Németh G.
    Schizophr Res; 2019 Feb 01; 204():282-288. PubMed ID: 30172595
    [Abstract] [Full Text] [Related]

  • 14. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR, Guo H, Németh G, Harsányi J, Thase ME.
    Psychopharmacol Bull; 2018 Jun 20; 48(4):62-80. PubMed ID: 30618475
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
    McEvoy JP, Daniel DG, Carson WH, McQuade RD, Marcus RN.
    J Psychiatr Res; 2007 Dec 20; 41(11):895-905. PubMed ID: 17631314
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Durgam S, Earley W, Li R, Li D, Lu K, Laszlovszky I, Fleischhacker WW, Nasrallah HA.
    Schizophr Res; 2016 Oct 20; 176(2-3):264-271. PubMed ID: 27427558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.
    Marder S, Fleischhacker WW, Earley W, Lu K, Zhong Y, Németh G, Laszlovszky I, Szalai E, Durgam S.
    Eur Neuropsychopharmacol; 2019 Jan 20; 29(1):127-136. PubMed ID: 30470662
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ, Lane R, Nuamah I, Gopal S, Hough D.
    J Am Acad Child Adolesc Psychiatry; 2015 Feb 20; 54(2):126-137.e1. PubMed ID: 25617253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.